We are proud to announce that vitalera, in partnership with the Maastricht University Medical Center+ (MUMC+), has been selected under the European-funded InnoMatch programme as one of the innovation procurement programs with the greatest potential for impact.

This milestone reflects the strength of our collaboration and our shared mission: to improve outcomes for breast cancer patients through AI-powered remote patient monitoring, the integration of health monitoring APIs and passive wearable data, and advanced clinical data intelligence.

Our innovation is designed not only to support patients throughout their surgical recovery but also to reduce hospitalizations, avoid unnecessary in-person visits, and prevent needless medical interventions. By shifting care beyond the hospital walls, patients benefit from continuous monitoring, early complication detection, and personalized feedback, while hospitals reduce strain on resources.

By combining the clinical leadership of MUMC+ with Vitalera’s digital health technology, we are taking a decisive step toward a new standard of decentralized recovery: more human, more efficient, and truly data-driven. Our vision is clear—to bring this innovation to patients across the Netherlands and, very soon, to healthcare systems throughout Europe.

Why Maastricht University Medical Center+ Matters

As one of the leading academic hospitals in the Netherlands, MUMC+ is recognized for its pioneering role in medical research, education, and patient-centered innovation. Its unique strength lies in combining world-class research with practical clinical expertise, making it a reference center not only in the Netherlands but across Europe.

MUMC+ has consistently led initiatives in:

• Cancer research and treatment: advancing precision medicine and surgical excellence.
• Digital health innovation: integrating new technologies into daily practice for better patient outcomes.
• Cross-border collaborations: working with European partners to pilot and scale new models of care.

By collaborating with vitalera through the InnoMatch program, MUMC+ demonstrates its commitment to shaping the future of healthcare delivery. Its participation validates the clinical relevance of our solution and ensures that innovations are tested under the most rigorous standards.

Transforming Postoperative Recovery With AI and Wearables

The joint pilot between Vitalera and MUMC+ focuses on improving outcomes for women undergoing DIEP flap breast reconstruction, a highly complex surgical procedure performed after mastectomy. While this surgery can significantly improve quality of life, recovery requires meticulous monitoring to detect complications early and support rehabilitation.

Our joint solution integrates:

• Garmin wearables to capture vital signs, mobility, and activity data.
• Passive data collection to ensure continuous monitoring without burdening patients.
• API for health monitoring to connect wearable and clinical data securely.
• AI-powered analytics to detect deviations and risks before they become complications.
• Patient engagement tools to encourage early mobilization and shared responsibility in recovery.

This proactive approach empowers both patients and clinicians. Patients benefit from continuous feedback and reassurance, while clinicians gain real-time insights that enable faster, data-driven interventions.

The Impact for Maastricht UMC+

For MUMC+, this pilot strengthens its role as a leader in innovation and delivers immediate benefits:

1. Enhanced Clinical Outcomes
   By adopting AI remote patient monitoring, MUMC+ can reduce complication rates, shorten hospital stays, and improve overall patient safety in breast cancer recovery.
2. Empowered Care Teams
   Continuous data collection through wearable and passive monitoring APIs reduces reliance on sporadic follow-up visits. Care teams gain a comprehensive, real-time picture of patient health, allowing for more efficient resource allocation.
3. Patient-Centered Innovation
   Patients at MUMC+ experience a more connected recovery journey, where they are supported beyond hospital walls. This aligns with the hospital’s mission to provide holistic, personalized care.
4. Scalable Model for Europe
   By validating this solution in a leading academic hospital, MUMC+ contributes to creating a European reference model for surgical recovery. This impact extends beyond breast cancer, paving the way for broader applications in other surgeries and chronic care pathways.

Advancing Digital Health With Interoperability

At the core of our solution is interoperability, making sure technology integrates seamlessly into healthcare environments to reduce unecesary visits and improve care outcomes remotely:

• API for health monitoring: Ensures data flows securely into hospital systems and electronic health records secure.
• API for wearable and passive data: Aggregates information from devices and patient-reported outcomes into one unified view.
• AI analytics: Reduce hospitalizations by transforming raw data into clinically actionable insights, helping clinicians act earlier and make smarter decisions.

By designing our solution with APIs and interoperability at its core, we are creating a flexible, scalable platform that can be adopted by hospitals across Europe.

Why This Partnership Sets a Benchmark

The collaboration between vitalera and MUMC+ demonstrates how technology providers and hospitals can work hand in hand to:

• Accelerate the adoption of AI remote patient monitoring in real clinical environments to reduce readmissions.
• Showcase the impact of wearable integration and passive data collection in surgical care.
• Deliver evidence-based outcomes that build trust and pave the way for widespread adoption.

For MUMC+, this pilot reaffirms its role as a hub for innovation and a driver of healthcare transformation. For Vitalera, it provides the opportunity to demonstrate how our scalable AI- remote patient platform can deliver tangible value in one of Europe’s most respected medical centers.

InnoMatch: Driving Healthcare Innovation Through Procurement

InnoMatch is powered by the EIC Innovation Procurement Programme, an initiative of the European Innovation Council (EIC). Its goal is to open procurement markets for innovative SMEs and start-ups in Europe and globally.

For healthcare innovators, one of the biggest challenges is gaining access to hospitals and first customers. InnoMatch addresses this by:

• Providing procurement and financial support across at least 38 programs.
• Creating market access opportunities by connecting innovators with hospitals and procurement partners.
• Ensuring validated, commercial-ready outcomes through structured testing and evaluation.

This framework ensures that innovation goes beyond theory and achieves practical adoption in real healthcare settings.

Scaling-up our partnerships

Being selected for InnoMatch is not only recognition but also an opportunity to scale innovation that matters. Together with Maastricht UMC+, we are proving that AI, wearable technology, and interoperable APIs can redefine how patients recover from major surgeries.

In the coming months, we will focus on deploying and validating the pilot, with the goal of creating a market-ready, scalable solution that enhances surgical recovery and can expand to other clinical areas.

Our vision is clear: to build the future of healthcare where patients are continuously supported, clinicians are empowered by data, and hospitals like Maastricht UMC+ lead the way in digital health transformation.

🔗 Learn more about InnoMatch: innomatchproject.eu